DeepQuake® Intravascular Lithotripsy (IVL) System

DeepQuake® is an innovative intravascular lithotripsy system for cardiovascular calcium. It delivers precise minimally invasive solutions specifically for severely calcified lesions in coronary and peripheral blood vessels. Comparing with conventional interventional approaches, DeepQuake IVL system successfully addresses calcification and significantly lowers the risk of procedural complications such as vascular dissection and perforation.

Based on the unique acoustic lithotripsy principle, the balloon catheter delivers pulsed shockwave energy to create micro-fractures within rigid calcified plaques. While preserving adjacent healthy soft vascular tissue, it effectively disrupts deep calcified tissue and prepares optimal vessel conditions for subsequent stent implantation, making interventional treatment for complex calcified lesions safer and more predictable.

DeepQuake® incorporates multiple differentiated innovative designs. It features multiple adjustable energy output, enabling flexible management of lesions ranging from mild to refractory severe calcification. The balloon is equipped with up to eight emitters for delivery of shockwave energy. An extra-long 80 mm balloon option is available to cover long diffuse lesions, eliminating the need for multiple overlapping dilations. This effectively shortens procedure time and reduces consumable usage.

Validated by rigorous multi-center clinical trials, DeepQuake® has obtained marketing approval and stepped into numerous Class A tertiary cardiac centers across China. As a benchmark domestic IVL product, DeepQuake® is boosting its global market presence. Powered by innovative technologies for cardiovascular intervention, it safeguards vascular health for more patients with calcified vascular lesions.